In one paragraphArticle in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
18 authors.
Shazia Ruybal-PesántezMRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, UK.ORCID 0000-0002-0495-179X Jorge Amaya-RomeroDepartment of Immunology and Infectious Disease, Harvard T.H. Chan School of Public Health, Harvard University, USA.
Mouhamadou Fadel DiopMedical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, The Gambia.ORCID 0000-0002-6569-6497 Kirsty McCannCentre for Innovation in Infectious Disease and Immunology Research (CIIDIR), The Institute for Mental and Physical Health and Clinical Translation (IMPACT), School of Medicine, Deakin University, Australia.ORCID 0000-0002-2427-241X Kathryn MurieEPPIcenter program, Division of HIV, ID, and Global Medicine, University of California San Francisco, USA.ORCID 0009-0008-9612-2016 Maxwell MurphyEPPIcenter program, Division of HIV, ID, and Global Medicine, University of California San Francisco, USA.ORCID 0000-0003-0332-4388 Stephen F SchaffnerDepartment of Immunology and Infectious Disease, Harvard T.H. Chan School of Public Health, Harvard University, USA.ORCID 0000-0001-6699-3568 Bryan GreenhouseEPPIcenter program, Division of HIV, ID, and Global Medicine, University of California San Francisco, USA.ORCID 0000-0003-0287-9111 Robert VerityMRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, UK.ORCID 0000-0002-3902-8567 Funding
Mentoring translational scientists in international infectious disease researchK24AI144048 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Bryan R Greenhouse · 2019 to 2026
$1.6MData and analysis ecosystem for eukaryotic pathogen targeted sequencingU01AI184646 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GREENHOUSE, BRYAN R · 2024 to 2025
$1.5MGates Foundation INV-031273NIAID NIH HHS K24 AI144048NIAID NIH HHS U01 AI184646
6 · The paper itselfAbstract
Identifiers
PMID40236429
PMCPMC11998834
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390